Telerad Tech announces its business expansion into four more countries

Telerad Tech (T2), a healthcare provider of AI-enabled teleradiology software,has expanded its presence further into four more countries namely Saudi Arabia, South Africa, Israel and Egypt.

The company acquired new clientele through its flagship products RADSpa and Clinspa.

“We are thrilled with the expansion we managed to make in 2020, with additional territories and increase in business revenues. We are expecting to grow our business 100% YOY for the next two years as healthcare providers continue to move towards telehealth with teleradiology being a key component of this shift,” said Kishor Joshi, Chief Business Officer of Telerad Tech. “We expect 2021 to continue this momentum, as we believe the market is prime for AI-based radiology workflow platforms and we look forward to working with new partners to enable them to start and expand their own teleradiology offerings.”

“GCC and Africa remain, perhaps, the fastest-growing and the most dynamic teleradiology market worldwide after the United States and hence represents an exceptional opportunity for us, helping us to meet our global product innovation and sales strategic goals,” he concludes.

Telerad Tech has more than 100 installations in 15 countries and has processed more than 20 million studies. The company’s flagship product RADSpa is an AI-enabled radiology workflow platform leveraged by a range of healthcare service providers from small diagnostic centers to large-scale multi-site, multi-geography healthcare centers and teleradiology service providers.

Telerad Tech was established in 2009 with the goal of optimizing radiology productivity and improving patient outcome delivery through transformational medical imaging software solutions.

+ posts

Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of  economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.

What's your take on this post ? Comment: